• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
27.4543251
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
9.89
30.55
EPS(TTM)
Face Value()
Div & Yield %
3.6
10
0
 

Basilic Fly Studio consolidated net profit declines 18.56% in the March 2026 quarter
May 30,2026
Net profit of Basilic Fly Studio declined 18.56% to Rs 13.60 crore in the quarter ended March 2026 as against Rs 16.70 crore during the previous quarter ended March 2025. Sales declined 15.12% to Rs 113.40 crore in the quarter ended March 2026 as against Rs 133.60 crore during the previous quarter ended March 2025.

For the full year,net profit rose 33.70% to Rs 48.80 crore in the year ended March 2026 as against Rs 36.50 crore during the previous year ended March 2025. Sales rose 34.10% to Rs 407.80 crore in the year ended March 2026 as against Rs 304.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales113.40133.60 -15 407.80304.10 34
OPM %21.0824.40 -20.8923.51 -
PBDT26.2030.50 -14 85.7067.30 27
PBT20.9027.00 -23 69.4055.10 26
NP13.6016.70 -19 48.8036.50 34